It activates over 100 genes involved in abnormal proliferation, metabolic reprogramming, invasion, metastasis, and therapy resistance, with elevated HIF-1α expression strongly correlated with tumor initiation, progression, and poor prognosis (150–152). Here, HIF1A is linked to neoplasm.